Functional Characterization of Variants of Unknown Significance of Fibroblast Growth Factor Receptors 1-4 and Comparison With AI Model-Based Prediction.

Journal: JCO precision oncology
Published Date:

Abstract

PURPOSE: Fibroblast growth factor receptors (FGFRs; FGFR1, FGFR2, FGFR3, FGFR4) are frequently mutated oncogenes in solid cancers. The oncogenic potential of FGFR rearrangements and few hotspot point mutations is well established, but the majority of variants resulting from point mutations especially outside of the tyrosine kinase domain are currently considered variants of unknown significance (VUS).

Authors

  • Martin Ziegler
    Nanoelektronik, Technische Fakultät, Christian-Albrechts-Universität zu Kiel, Kiel 24143, Germany.
  • Nadira Khoury
    DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.
  • Louisa Maxine Hommerich
    DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.
  • Heike Adler
    DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.
  • Sonja Loges
    DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany.